Sarah Kidd - Concepedia

Author

Sarah Kidd

South Australia Pathology ORCID

Also Known As

Hunter Cooper, Karina Kennedy, Kidd, S., Michael Judd, P Hamal, S KIDD, S Kidd, S. E. Kidd, S. Kidd, S.E. Kidd

255

Publications

16.5K

Citations

H-Index

116

Concepts

All Affiliations

South Australia Pathology The University of Sydney Centers for Disease Control and Prevention Westmead Hospital Peter MacCallum Cancer Centre

About

Sarah Kidd is an author at South Australia Pathology specializing in medicine, epidemiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	32	2.8K
2	Public Health	16	18	2.6K
3	Health Sciences	4	4	748
4	Engineering	2	2	75
5	Natural Sciences	2	2	127

Sarah Kidd

Publications

14.6K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2020	5K
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2021	1.2K
Sexually transmitted disease surveillance 2017 Jim Braxton, Darlene W. Davis, Brian Emerson, Sexual HealthInfectious Disease EpidemiologyClinical EpidemiologySocial SciencesDisease Surveillance	2018	1K
A rare genotype of <i>Cryptococcus gattii</i> caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada) Sarah Kidd, Ferry Hagen, R. L. Tscharke, Proceedings of the National Academy of Sciences	2004	768
Prospective Multicenter International Surveillance of Azole Resistance in<i>Aspergillus fumigatus</i> Jan W. M. van der Linden, Maiken Cavling Arendrup, Adilia Warris, Emerging infectious diseases Fungal DiversityClinical Aspergillus IsolatesAntifungal AgentAzole ResistanceHealth Sciences	2015	356
Spread of<i>Cryptococcus gattii</i>in British Columbia, Canada, and Detection in the Pacific Northwest, USA Laura MacDougall, Sarah Kidd, Eleni Galanis, Emerging infectious diseases	2007	283
Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial Martin Dennis, Gillian Mead, John Forbes, The Lancet	2018	276
Epidemiology of<i>Cryptococcus gattii</i>, British Columbia, Canada, 1999–2007 Eleni Galanis, Laura MacDougall, Sarah Kidd, Emerging infectious diseases Largest Reported PopulationMicrobial DiseaseAntibioticsClinical Infectious DiseaseVgiib Strain	2010	262
Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole Ana Espinel‐Ingroff, Ana Isabel Aller, Laura Rosío Castañón-Olivares, Antimicrobial Agents and Chemotherapy Diagnostic MycologyPathogenic MicrobiologyPathogen DetectionClinical MycologyClsi Mics	2012	246
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States Sarah Kidd, Yat Chow, Sunny Mak, Applied and Environmental Microbiology	2006	236

Page 1